Initial Phase 3 Results Of The First (Frontline Investigation Of Lenalidomide plus Dexamethasone Versus Standard Thalidomide) Trial (MM-020/IFM 07 01) In Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) Ineligible For Stem Cell Transplantation (SCT)
D O I:
10.1182/blood.V122.21.2.2